Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001501271 | SCV001706078 | likely benign | Brugada syndrome 4 | 2023-09-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390758 | SCV002704837 | likely benign | Cardiovascular phenotype | 2021-07-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV001501271 | SCV002799057 | likely benign | Brugada syndrome 4 | 2021-07-12 | criteria provided, single submitter | clinical testing |